The ID NOW™ COVID-19 rapid test by Abbott delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene. Medtech Maldives reveals the company will be bringing the product to the Maldives.
Timely results enable healthcare professionals to make appropriate and more efficient treatment and infection control decisions. EUA supports flexible near-patient testing environments.
The benefits include positive results detected in as little as 5 minutes, negative results in 13 minutes and molecular technology targeting COVID-19 RdRp gene. The product is designed for near-patient testing in a variety of healthcare environments.
Full details are available at the link below:
